APOTHEEK BRABANTDAM: what changed
What changed
APOTHEEK BRABANTDAM
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€2,232
2024 · -€25,730+€27,963
Equity
€48,921
2024 · €46,689+€2,232
Cash
€61,840
2024 · €73,082-€11,242
Balance sheet total
€93,195
2024 · €91,848+€1,347
Largest movements
Assets
- Receivables within one year +€17,401
up €17,401 (+213%), from €8,155 to €25,555
of which Trade receivables: +€20,715
- Cash -€11,242
down €11,242 (-15.4%), from €73,082 to €61,840
mainly Receivables within one year (-€17,401) and Debts after one year (-€4,471)
- Tangible fixed assets -€4,969
down €4,969 (-52.2%), from €9,516 to €4,547
Equity and liabilities
- Debts after one year -€4,471
down €4,471 (-100%), from €4,471 to €0
- Tax, wage and social debts +€3,727
up €3,727 (+512%), from €728 to €4,454
of which Taxes: +€3,727
- Reserves +€2,232
up €2,232 (+6.0%), from €37,389 to €39,621
Income statement
- Gross operating margin +€27,737
up €27,737, from -€19,766 to €7,971
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
-€25,730
Gross operating margin
+€27,737
Other operating charges
-€27
Financial charges
+€141
Taxes
+€112
Result 2025
€2,232
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
-€6,416
Investment
€0
Financing
-€4,826
Cash 2024
€73,082
From operations (derived)
-€6,416
Net result for the year
+€2,232
Depreciation
+€4,969
Receivables within one year
-€17,401
Deferred charges and accrued income
-€158
Trade debts
-€131
Tax, wage and social debts
+€3,727
Other debts
+€345
Financing
-€4,826
Debts after one year
-€4,471
Current portion of long-term debt
-€355
Cash 2025
€61,840
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €91,848 | €93,195 | +€1,347 | +1.5% |
| Fixed assets | 21/28 | €9,516 | €4,547 | -€4,969 | -52.2% |
| Tangible fixed assets | 22/27 | €9,516 | €4,547 | -€4,969 | -52.2% |
| Furniture and vehicles | 24 | €9,516 | €4,547 | -€4,969 | -52.2% |
| Current assets | 29/58 | €82,332 | €88,648 | +€6,316 | +7.7% |
| Amounts receivable within one year | 40/41 | €8,155 | €25,555 | +€17,401 | +213% |
| Trade receivables | 40 | €4,840 | €25,555 | +€20,715 | +428% |
| Other amounts receivable | 41 | €3,315 | €0 | -€3,315 | -100% |
| Cash at bank and in hand | 54/58 | €73,082 | €61,840 | -€11,242 | -15.4% |
| Deferred charges and accrued income | 490/1 | €1,096 | €1,253 | +€158 | +14.4% |
| Total equity and liabilities | 10/49 | €91,848 | €93,195 | +€1,347 | +1.5% |
| Equity | 10/15 | €46,689 | €48,921 | +€2,232 | +4.8% |
| Contributions | 10/11 | €9,300 | €9,300 | = | 0.0% |
| Reserves | 13 | €37,389 | €39,621 | +€2,232 | +6.0% |
| Distributable reserves | 133 | €37,389 | €39,621 | +€2,232 | +6.0% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €45,159 | €44,274 | -€885 | -2.0% |
| Amounts payable after more than one year | 17 | €4,471 | €0 | -€4,471 | -100% |
| Financial debts | 170/4 | €4,471 | €0 | -€4,471 | -100% |
| Amounts payable within one year | 42/48 | €40,688 | €44,274 | +€3,586 | +8.8% |
| Current portion of amounts payable after more than one year | 42 | €4,826 | €4,471 | -€355 | -7.4% |
| Trade debts | 44 | €140 | €9 | -€131 | -93.5% |
| Suppliers | 440/4 | €140 | €9 | -€131 | -93.5% |
| Taxes, remuneration and social security | 45 | €728 | €4,454 | +€3,727 | +512% |
| Taxes | 450/3 | €728 | €4,454 | +€3,727 | +512% |
| Remuneration and social security | 454/9 | €0 | - | = | |
| Other amounts payable | 47/48 | €34,994 | €35,339 | +€345 | +1.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,969 | €4,969 | = | 0.0% |
| Other operating charges | 640/8 | €399 | €427 | +€27 | +6.9% |
| Gross operating margin | 9900 | -€19,766 | €7,971 | +€27,737 | |
| Operating profit (loss) | 9901 | -€25,135 | €2,575 | +€27,710 | |
| Financial income | 75/76B | €0 | - | = | |
| Recurring financial income | 75 | €0 | - | = | |
| Financial charges | 65/66B | €484 | €343 | -€141 | -29.1% |
| Recurring financial charges | 65 | €484 | €343 | -€141 | -29.1% |
| Profit (loss) for the period before taxes | 9903 | -€25,619 | €2,232 | +€27,851 | |
| Income taxes | 67/77 | €112 | -€0 | -€112 | |
| Profit (loss) for the period | 9904 | -€25,730 | €2,232 | +€27,963 | |
| Profit (loss) for the period to be appropriated | 9905 | -€25,730 | €2,232 | +€27,963 |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.